Mr Dan Janiak

KANDO id: 40245

Bio

Dan Janiak is an Associate with DFJ Mercury, where he focuses on developing and originating science-based investment themes and startup opportunities. Prior to DFJ Mercury, Dan was an Associate in the Physical and Biological Technologies practice at In-Q-Tel, the strategic venture investment arm of the U.S. Intelligence Community. While at In-Q-Tel, Dan was responsible for the management and oversight of technology development programs in numerous In-Q-Tel portfolio companies including QD Vision, Seventh Sense Biosystems, Sionex, and SpectraFluidics. In addition, he was responsible for leading technical due diligence on all potential investment candidates in the advanced materials space. Dan received his BS and PhD in Materials Science and Engineering from the University of Maryland. While at Maryland, Dan was a Future Faculty Fellow and held the Robert E. Fischell Fellowship in Biomedical Engineering, conducting research in the design, synthesis and characterization of artificial antibodies with applications in medical diagnostics and biopharmaceutical purification.

Education